Tango Therapeutics (TNGX) Non-Current Assets (2020 - 2026)

Tango Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $43.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 11.97% year-over-year to $43.5 million; the TTM figure through Mar 2026 stood at $182.5 million (down 10.59% YoY), while the FY2025 annual figure was $44.9 million, down 10.4% from the prior year.
• Non-Current Assets was $43.5 million for Q1 2026 at Tango Therapeutics, down from $44.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $62.5 million in Q3 2022 to a low of $10.9 million in Q1 2022.
• Historically, Non-Current Assets has averaged $48.3 million across 5 years, with a median of $51.6 million in 2024.
• Biggest YoY gain for Non-Current Assets was 682.88% in 2022; the steepest drop was 93.48% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $61.2 million in 2022, then dropped by 8.45% to $56.0 million in 2023, then retreated by 10.49% to $50.1 million in 2024, then dropped by 10.4% to $44.9 million in 2025, then decreased by 3.27% to $43.5 million in 2026.
• The last three Non-Current Assets figures came in at $43.5 million (Q1 2026), $44.9 million (Q4 2025), and $46.4 million (Q3 2025), per Business Quant data.